Strategic Partnerships Target distribution and collaboration opportunities with endoscopy and surgical device manufacturers that could integrate or bundle Virtual Incision's miniaturized robotic-assisted surgery platform with existing platforms, expanding reach into ORs and private clinics.

regula tory Progress Leverage FDA De Novo clearance for MIRA as a trust signal to hospital systems and surgeons, and position for potential early-adopter procurement programs, pilot studies, and volume-based pricing discussions.

Capital Momentum Capitalize on recent investments and funding traction to secure strategic customers and co-development deals, emphasizing the company’s growth trajectory and ongoing expansion into Lincoln facilities to support scale.

Global Expansion Identify international markets and multi-region hospital networks seeking RAS capabilities by highlighting miniaturization benefits, easier integration, and potential cost savings in OR time and patient recovery.

Intellectual Leverage Promote the extensive patent portfolio as a moat for customers seeking long-term reliability and vendor stability, while offering joint development opportunities with academic centers to validate clinical benefits and drive adoption.